MITSUBISHI HEAVY INDUSTRIES THERMAL SYSTEMS, LTD. (Japan)
UNIVERSITY PUBLIC CORPORATION OSAKA (Japan)
Inventor
Cui, Linri
Sakai, Masanobu
Mihara, Shinji
Nishioka, Masatoshi
Nakao, Masaki
Abstract
This control device comprises: an operation control unit capable of switching the operation mode of a geothermal utilization system between a heating mode in which water pumped up from a hot water well is returned to a cold water well and a cooling mode in which water pumped up from a cold water well is returned to a hot water well; a calculation unit that calculates the integrated heat storage amount of a past heating operation period during which the operation was performed in the heating mode, and the integrated heat storage amount of a past cooling operation period during which the operation was performed in the cooling mode; and an operation state adjustment unit that adjusts the operation state of the geothermal heat utilization system such that the difference between the integrated heat storage amount of a subsequent heating operation period and the integrated heat storage amount of a subsequent cooling operation period is smaller than the difference between the integrated heat storage amount of the past heating operation period and the integrated heat storage amount of the past cooling operation period.
F24T 10/20 - Geothermal collectors using underground water as working fluidGeothermal collectors using working fluid injected directly into the ground, e.g. using injection wells and recovery wells
F24F 5/00 - Air-conditioning systems or apparatus not covered by group or
F24F 11/67 - Switching between heating and cooling modes
F24F 11/875 - Control systems characterised by their outputsConstructional details thereof for controlling the temperature of the supplied air by controlling heat-storage apparatus
The purpose of the present invention is to: use a relatively simple preparation method to provide a hollow particle of which the decomposition product is a component contained in a plant or a derivative thereof; and provide a method for producing said hollow particle. This purpose can be achieved by means of, inter alia, a hollow particle containing a plurality of (poly)glycerol ester compounds which are reaction products of a cinnamic acid and/or cinnamic acid derivative represented by general formula (1) (wherein each among R1-R5 independently represents any of a hydrogen atom, a C1-6 alkyl group, a C1-6 alkoxy group, a nitro group, an amino group, an alkylamino group, or a hydroxyl group, and X represents any of a hydroxyl group, fluorine, chlorine, bromine, or iodine) and a (poly)glycerol having an average degree of polymerization of 1-40, wherein at least some of the cinnamoyl groups that are included in (poly)glycerol ester compounds and derived from the cinnamic acid or from the cinnamic acid derivative are photodimerized.
C08G 65/332 - Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides or esters thereof
Provided is a kit for detecting a glycoprotein contained in a sample using an optical condensation system, the kit comprising microparticles modified by host molecules and a dilution solution for diluting the sample, in which each of the host molecules binds specifically to the glycoprotein, the dilution solution comprises a blocking agent and a buffering agent, the pH value of the dilution solution is higher than the isoelectric point of the glycoprotein, the concentration of the blocking agent is lower than a concentration at which the non-specific adsorption between the host molecules is inhibited in an environment where a light-induced force does not act on the host molecules, and the salt concentration in the dilution solution is a concentration at which the microparticles modified by the host molecules cannot be precipitated by salting out.
Provided are a breath visualization system and method, a breath evaluation system and method, and a health evaluation system and method having simple configurations and capable of ensuring visualization of breath even when a front image of a face of a subject is captured by a camera. A breath visualization system comprising: an infrared camera that detects light in the infrared region emitted from a face of a subject to obtain image data; a processing unit that subtract, from first image data obtained at a first time (certain arbitrarily selected time), second image data obtained at second time (prior to the certain arbitrarily selected time) prior to the first time, to generate processed image data; and an output unit that outputs the processed image data.
The present disclosure relates to a uPAR-binding HLH peptide and a peptide−drug conjugate (PDC) in which a drug is linked to the uPAR-binding HLH peptide.
C07K 14/00 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
The present invention addresses the problem of providing a culture medium having a lower degree of growth inhibition with respect to Escherichia albertii while containing tellurous acid and/or a salt thereof. The aforementioned problem is solved by a culture medium for bacteria, the culture medium containing tellurous acid and/or a salt thereof, and at least two components selected from the group consisting of phosphoric acid and/or salts thereof, non-meat raw-material peptones, polyvalent metal ions, and glucose.
C12N 1/00 - Microorganisms, e.g. protozoaCompositions thereofProcesses of propagating, maintaining or preserving microorganisms or compositions thereofProcesses of preparing or isolating a composition containing a microorganismCulture media therefor
7.
MICROORGANISM ACCUMULATION METHOD AND ACCUMULATION SYSTEM
A microorganism accumulation method includes setting a laser light irradiation condition, and irradiating a plurality of pores with laser light through a sample in accordance with the irradiation condition. A region irradiated with the laser light does not include a photothermal conversion material. The setting of the irradiation condition includes setting intensity of non-resonant light within an irradiation range of the non-resonant light such that a magnitude of a vertically downward component of a light-induced force caused by irradiation with the non-resonant light (i) is greater than a magnitude of a vertically upward component of a buoyancy force caused by the liquid sample and (ii) is greater than a magnitude of a vertically upward component of a force caused by a Brownian motion of molecules in the liquid sample.
The present invention provides a prediction method (modified thermal shrinkage method) that can quickly and accurately predict a deformation or a residual stress caused by returning temperature of an object subjected to heating to room temperature. The prediction method of the present invention is a method for predicting a deformation or a residual stress caused by returning temperature of an object subjected to heating to room temperature, including: a condition setting step of setting a first shrinkage zone and a second shrinkage zone in an analytical model of the object, and setting a first change in temperature of the first shrinkage zone and a second change in temperature of the second shrinkage zone; and an analysis step of performing an elastic analysis or an elastic-plastic analysis by giving a first shrinkage strain calculated from the first change in temperature to the first shrinkage zone and by giving a second shrinkage strain calculated from the second change in temperature to the second shrinkage zone.
B23K 31/12 - Processes relevant to this subclass, specially adapted for particular articles or purposes, but not covered by any single one of main groups relating to investigating the properties, e.g. the weldability, of materials
G01N 33/207 - Welded or soldered jointsSolderability
Provided is a piezoelectric constant measuring device capable of accurately measuring a piezoelectric constant d33 even when a load applied to a piezoelectric thin film on a wafer is small. A piezoelectric constant measuring device 1 measures a piezoelectric constant d33 of a piezoelectric thin film W3 formed on a wafer WA, and comprises: a wafer table 2; a first electrode 3 which can be in contact with a predetermined portion of the wafer WA; a second electrode 4; a second electrode load means 5 which is controlled by a reference frequency signal and can apply a periodic load to the piezoelectric thin film W3 via the second electrode 4; a load measuring means 6 that outputs the amplitude value of the periodic load or a value proportional to the amplitude value; a reference frequency signal generator 7 that outputs the reference frequency signal; a lock-in amplifier 8 to which is input through the second electrode 4, as a signal to be measured, a current due to an electric charge generated in the piezoelectric thin film W3, and to which is input the reference frequency signal as a reference signal, and which outputs the amplitude value of the signal to be measured or a value proportional thereto; and a piezoelectric constant measurement control means 9 that calculates the piezoelectric constant d33.
αi1-xi1-xiTMixi44 (in the formula, αi is 0 to 6 inclusive, xi is 0 to 0.6 inclusive, and TMiαii2-xii2-xiiTMiixii66 (in the formula, αii is 0 to 8 inclusive, xii is 0 to 0.6 inclusive, and TMii is a transition metal). Consequently, the present invention provides a novel positive electrode active material that is useful for a sodium ion battery.
H01M 4/58 - Selection of substances as active materials, active masses, active liquids of inorganic compounds other than oxides or hydroxides, e.g. sulfides, selenides, tellurides, halogenides or LiCoFySelection of substances as active materials, active masses, active liquids of polyanionic structures, e.g. phosphates, silicates or borates
Provided is a ferroelectric device (1) comprising a single-crystal silicon substrate (10), a titanium nitride layer (20), a chromium vanadium layer (30), a platinum electrode layer (40), and a ferroelectric thin film (50), the ferroelectric device (1) being such that the titanium nitride layer (20), the chromium vanadium layer (30), the platinum electrode layer (40), and the ferroelectric thin film (50) are laminated in the stated order on the single-crystal silicon substrate (10).
H10N 30/076 - Forming of piezoelectric or electrostrictive parts or bodies on an electrical element or another base by depositing piezoelectric or electrostrictive layers, e.g. aerosol or screen printing by vapour phase deposition
C23C 14/06 - Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the coating material
H10N 30/06 - Forming electrodes or interconnections, e.g. leads or terminals
H10N 30/079 - Forming of piezoelectric or electrostrictive parts or bodies on an electrical element or another base by depositing piezoelectric or electrostrictive layers, e.g. aerosol or screen printing using intermediate layers, e.g. for growth control
H10N 30/85 - Piezoelectric or electrostrictive active materials
This trunk rotation restriction supporter comprises a first mounting part and a second mounting part. The first mounting part is mounted around the waist of a user. The second mounting part is mounted around a shoulder of the user on one of the left and right sides, and is connected to the first mounting part. In a state where the first mounting part is mounted on the user, the second mounting part is connected to the first mounting part only at a portion of the first mounting part that is located on the waist of the user on the other of the left and right sides. In a state where the first mounting part and the second mounting part are mounted on the user, the second mounting part extends from the portion of the first mounting part toward the shoulder.
NATIONAL UNIVERSITY CORPORATION YAMAGATA UNIVERSITY (Japan)
CELL ENGINEERING CORPORATION (Japan)
Inventor
Nakanishi Takeshi
Tachibana Taro
Kitamura Masaya
Makabe Koki
Yoshimura Saori
Abstract
To provide a novel polypeptide comprising an isopeptide bond. In one aspect, provided is a polypeptide comprising an isopeptide bond between first and second polypeptide chains, the polypeptide comprising: a) lysine; b) glutamine, glutamic acid, asparagine or aspartic acid; and c) glutamic acid or aspartic acid, wherein the first and second polypeptide chains each comprise a) and b) in a boundary region in which the first and second polypeptide chains in the three-dimensional structure of the polypeptide are adjacent to each other.
A stereoscopic display device includes an optical element configured to restrict a (2h−1)th image for a right eye of an hth (h: a natural number) observer and a 2hth image for a left eye of the hth observer to a position where visual recognition is possible and a display having a display surface including a plurality of pixels arranged in a first direction and a second direction and configured to display the (2h−1)th image and the 2hth image. A control process is performed so that at least one of a (2h−1)th viewpoint region where the (2h−1)th image is visually recognizable and a 2hth viewpoint region where the 2hth image is visually recognizable is wider than a distance between the eyes of the observer, the (2h−1)th image is displayed on (n(2h−1)) pixels, the 2hth image is displayed on (n(2h)) pixels, and a position of at least one of a (2h−1)th interocular boundary that is a boundary between the right eye and the left eye of the hth observer and a (2h−1)th interobserver boundary that is a boundary between the hth observer and an (h+1)th observer is moved on the basis of position data indicating positions of the eyes of the hth observer.
A microscopic object condensation method includes first to third steps. The first step is a step of preparing an optical fiber including a tip end provided with a metallic thin film. The second step is a step of arranging the tip end of the optical fiber in liquid where a plurality of microscopic objects are dispersed. The third step is a step of generating convection by heating of liquid around the tip end of the optical fiber by introduction of light at a wavelength included in a range of an absorption wavelength of the metallic thin film into the optical fiber.
C12Q 1/04 - Determining presence or kind of microorganismUse of selective media for testing antibiotics or bacteriocidesCompositions containing a chemical indicator therefor
G01N 21/31 - Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
In order to provide a personal authentication method that does not require image alignment each time a target is measured and also does not require template matching, this personal authentication method is configured so that a computer: acquires hyperspectral imaging data of a target; sets a region of interest for the acquired hyperspectral imaging data; extracts spectral information in the region of interest; and uses the extracted spectral information to evaluate similarities to pre-registered data.
22222S component is 47.0 mol% to 67.0 mol% if the total amount of the inorganic sulfide is taken as 100 mol%; and the glass phase is the main phase. This inorganic sulfide is glass that can be easily produced and has a large amount of sodium.
C03C 3/076 - Glass compositions containing silica with 40% to 90% silica by weight
C03C 3/32 - Non-oxide glass compositions, e.g. binary or ternary halides, sulfides, or nitrides of germanium, selenium or tellurium
C03C 3/062 - Glass compositions containing silica with less than 40% silica by weight
H01B 1/06 - Conductors or conductive bodies characterised by the conductive materialsSelection of materials as conductors mainly consisting of other non-metallic substances
H01B 1/10 - Conductors or conductive bodies characterised by the conductive materialsSelection of materials as conductors mainly consisting of other non-metallic substances sulfides
H01M 4/62 - Selection of inactive substances as ingredients for active masses, e.g. binders, fillers
H01M 10/054 - Accumulators with insertion or intercalation of metals other than lithium, e.g. with magnesium or aluminium
The present invention provides: an anti-gpNMB antibody that binds to gpNMB and affects the same and that has an effect of such as removal of dysfunctional microglia; and a use application of the anti-gpNMB antibody. The anti-gpNMB antibody specifically binds to at least one site in a region from a PMEL-CAF-like domain to a PKD domain of gpNMB.
C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
A61K 39/00 - Medicinal preparations containing antigens or antibodies
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
19.
ALKALI DEVELOPING SOLUTION AND PATTERN FORMATION METHOD USING SAME
According to the present invention, resolution is improved by adding a small amount of an organic solvent in development of a positive photosensitive polyimide resin. Provided is an alkali developing solution for positive photosensitive polyimides, the alkali developing solution being used when a photosensitive layer formed from a positive photosensitive resin composition including a diazonaphthoquinone-containing polyimide structure is exposed in a pattern form and then developed, wherein (poly)glycerol is contained in an alkaline aqueous solution. The (poly)glycerin content of the alkali aqueous solution is 1-4 mass%.
The present invention provides a substance which exerts an antitumor effect by causing alterations in the tumor microenvironment (TME), including the inhibition or suppression of TME formation. The present invention is directed to an antibody against human CXCL1 or an antibody fragment thereof, which has particular CDR sequences.
C07K 16/24 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
A61K 39/00 - Medicinal preparations containing antigens or antibodies
An optical sensor (1) detects a detection target substance. The optical sensor (1) comprises a photonic crystal base material (11) and a resin film (12). The photonic crystal base material (11) has a main surface (13) on which a plurality of minute periodic structures (14) are disposed. The resin film (12) covers at least a portion of the main surface (13) and has a boundary surface (15) having a shape complementary to the plurality of minute periodic structures (14). The resin film (12) includes a host substance (121) that selectively reacts with the detection target substance.
G01N 21/27 - ColourSpectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection
G01N 21/41 - RefractivityPhase-affecting properties, e.g. optical path length
G01N 21/77 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
22.
POLYPEPTIDE, FUSION PROTEIN, METHOD FOR PRODUCING FUSION PROTEIN, METHOD FOR LOCALIZING PROTEIN IN EXOSOME, EXOSOME, AND METHOD FOR PRODUCING EXOSOME
Provided is a polypeptide for localizing a fusion protein of a protein and the polypeptide in an exosome by being added to the C-terminus of the protein, wherein, in the polypeptide, the N-terminal amino acid sequence includes an amino acid sequence represented by formula 1 and the C-terminal amino acid sequence includes an amino acid sequence represented by formula 2. Formula 1: K-X11-X12-X13-K, wherein X11and X12each independently represent any one amino acid residue selected from the group consisting of an L-lysine residue, an L-arginine residue, an L-serine residue, an L-threonine residue, and an aliphatic amino acid residue, and X13represents an L-lysine residue or an L-arginine residue. Formula 2: C-X21-X22-X23, wherein X21and X22each independently represent an aliphatic amino acid residue, and X23 represents an amino acid residue.
The purpose of the present invention is to provide a culture medium for immature eggs that is excellent in quality and safety and that is capable of efficiently maturing immature eggs with respect to immature eggs for vitro maturation-in vitro fertilization-embryo transfer method (IVM-IVF). The present invention is a composition that is for treating immature eggs and/or embryos (fertilized eggs) and that contains a serum-free mesenchymal stem cell culture medium. The treatment composition is suitably used as an immature egg culture agent, an embryo (fertilized egg) culture agent, an implantation adjuvant, an embryo transfer liquid or an implantation rate improver.
This video display device comprises: a viewpoint location limitation unit that has an optical element for limiting a first viewpoint location and a second viewpoint location; an image display unit that has a display surface including a plurality of pixels and displays a first image and a second image on the display surface; and a control unit that allocates, to each of the pixels included in the display surface, an image value based on at least the first image or the second image. The control unit: allocates a pixel value based on the first image to at least a part of the pixels which are observed from the first viewpoint location through the optical element; allocates a pixel value based on the second image to at least a part of the pixels which are observed from the second viewpoint location through the optical element; and allocates, to at least a part of the pixels which are observed from the first viewpoint location through the optical element and are also observed from the second viewpoint location through the optical element, a synthesized pixel value obtained by synthesizing the pixel value based on the first image and the pixel value based on the second image at a prescribed synthesis ratio.
H04N 13/125 - Improving the 3D impression of stereoscopic images by modifying image signal contents, e.g. by filtering or adding monoscopic depth cues for crosstalk reduction
G02B 30/27 - Optical systems or apparatus for producing three-dimensional [3D] effects, e.g. stereoscopic images by providing first and second parallax images to an observer’s left and right eyes of the autostereoscopic type involving lenticular arrays
G02B 30/30 - Optical systems or apparatus for producing three-dimensional [3D] effects, e.g. stereoscopic images by providing first and second parallax images to an observer’s left and right eyes of the autostereoscopic type involving parallax barriers
H04N 13/31 - Image reproducers for viewing without the aid of special glasses, i.e. using autostereoscopic displays using parallax barriers
H04N 13/366 - Image reproducers using viewer tracking
An N-pole rotor (1A) for an electric motor according to an embodiment of the present invention includes a plurality of pole regions (2) divided into N equal sections around an axis of rotation (10). The overall shape of the plurality of pole regions (2) is rotationally symmetrical about the axis of rotation (10) and line-symmetrical with respect to a specified line that passes through the axis of rotation (10). The pole regions (2) include at least four asymmetrical pole regions (22), each of the asymmetrical pole regions (22) having an asymmetrical shape with respect to a center line (20) of said asymmetrical pole region (22).
Provided is a coating composition containing a solvent and a polymer, wherein the polymer contains a graft-type polymer compound (A) that contains a constituent unit represented by general formula (1) and has a crosslinkable functional group (a), and a crosslinkable polymer compound (B) that has two or more reactive functional groups (b) that undergo a crosslinking reaction with the crosslinkable functional group (a), and the content ratio of the crosslinkable polymer compound (B) in a total of 100 mass% of the graft-type polymer compound (A) and the crosslinkable polymer compound (B) is 0.1 mass% or more but less than 50 mass%.
C09D 151/06 - Coating compositions based on graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bondsCoating compositions based on derivatives of such polymers grafted on to homopolymers or copolymers of aliphatic hydrocarbons containing only one carbon-to-carbon double bond
C08G 81/02 - Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
C09D 125/02 - Homopolymers or copolymers of hydrocarbons
C09D 133/00 - Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereofCoating compositions based on derivatives of such polymers
C09D 201/00 - Coating compositions based on unspecified macromolecular compounds
A lighting device according to one aspect of the present invention includes a plurality of thin plates whose surfaces facing a center are configured to absorb light. By rearranging the at least one thin plate by moving the at least one thin plate at an angle smaller than 360 degrees about an axis, it is possible to form a curved plate having a double right-angled spherical triangular shape by all of the plurality of thin plates.
Provided is a member that is for suppressing formation of ice nucleus, suppressing formation of frost, and suppressing accretion of snow and ice, and that has a coating film obtained through application of a coating composition containing a solvent and a polymer. The polymer contains: a graft polymer compound (A) that includes a structural unit represented by general formula (1) and that has a crosslinkable functional group (a); and a crosslinkable polymer compound (B) that has two or more reactive functional groups (b) that undergo a cross-linking reaction with the crosslinkable functional group (a). The content proportion of the crosslinkable polymer compound (B) in a total of 100 mass% of the graft polymer compound (A) and the crosslinkable polymer compound (B) is not less than 0.1 mass% but less than 50 mass%. The ice accretion stress of the member at -18°C is 150 kPa or less.
C09D 151/00 - Coating compositions based on graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bondsCoating compositions based on derivatives of such polymers
C09K 3/18 - Materials not provided for elsewhere for application to surface to minimize adherence of ice, mist or water theretoThawing or antifreeze materials for application to surfaces
29.
CLINICAL TEST ASSISTANCE DEVICE, CLINICAL TEST ASSISTANCE PROGRAM, CLINICAL TEST ASSISTANCE MODEL, AND CLINICAL TEST ASSISTANCE METHOD
A clinical test assistance device (100) comprises: a measured value acquisition unit (121) that acquires measured values regarding each of a plurality of specimens that are successively collected from a plurality of test subjects; a bias adjustment unit (122) that applies a bias value to a portion of the plurality of measured values; a training unit (123) that generates a trained model which has been trained, treating a dataset that includes a set of measured values to which a bias value was not applied and a set of measured values to which a bias value was applied as training data, such that by setting the measured value of an evaluation specimen and the measured value of a specimen collected before the evaluation specimen as input values, the trained model outputs a value indicating the probability that an error was occurring in a measurement system when the measured value of the evaluation specimen was inputted; and a suitability determination unit (124) that, by setting the respective measured values of a target specimen and a specimen collected before the target specimen as input values of the trained model, determines whether an error was occurring in the measurement system when the measured value of the target specimen was inputted.
G16H 10/40 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
This respiratory function diagnostic device comprises: an image acquisition unit for acquiring a chest image as an X-ray image that includes the chest of a prediction subject (subject for whom a prediction is to be made); a respiration prediction unit for setting as an input value, with respect to a mathematical model for predicting from a chest image a respiration value serving as an index for respiration function, a chest image acquired for the prediction subject, and thereby predicting the respiration value for the prediction subject; and a learning unit for adjusting the mathematical model by using the chest image of an experimental subject as an input value and using the actual measurement value of the respiration value for the experimental subject as an output value.
A61B 6/46 - Arrangements for interfacing with the operator or the patient
A61B 6/00 - Apparatus or devices for radiation diagnosisApparatus or devices for radiation diagnosis combined with radiation therapy equipment
A61B 6/50 - Apparatus or devices for radiation diagnosisApparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body partsApparatus or devices for radiation diagnosisApparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific clinical applications
31.
MICRO-OBJECT COLLECTION METHOD AND COLLECTION SYSTEM
A micro-object collection method according to the present invention is for collecting a plurality of micro-objects included in a sample. The micro-object collection method comprises first to third steps. The first step is for preparing an integrated substrate (13) that is provided with a plurality of pores (15) each having a partition wall (15b) separating adjacent openings (15a). The second step is for introducing a sample into the integrated substrate (13). The third step is for irradiating the plurality of pores (15) with a laser beam focused by a lens. The irradiation step includes a step for scanning the plurality of pores (15) with the beam waist of the laser beam.
B01J 19/12 - Processes employing the direct application of electric or wave energy, or particle radiationApparatus therefor employing electromagnetic waves
The present invention provides a nano-sized metal complex in which volume change on the occasion of temperature change is suppressed. The present invention pertains to a metal complex that has a crystallite diameter of 60 nm or less and is represented by general formula (1). Formula (1): (M1pp[(M2q622O (in the formula, M1represents at least one item selected from the group consisting of Ag (I), Au (I), and Cu (I), M2 represents at least one trivalent transition metal, p is a positive number between 2.5 and 3.5 inclusive, q is a positive number between 0.5 and 1.5 inclusive, p + q is a positive number between 3.5 and 4.5 inclusive, and n is 0 or a positive number).
Provided are: an anti-gpNMB antibody that binds to gpNMB to act on the gpNMB and has properties including a property to remove dysfunctional microglia; and a use of the anti-gpNMB antibody. A humanized anti-gpNMB antibody according to the present invention binds specifically to at least one site in a region lying between a PMEL-CAF-like domain and a PKD domain of gpNMB.
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
A61K 31/713 - Double-stranded nucleic acids or oligonucleotides
A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
A61K 38/02 - Peptides of undefined number of amino acidsDerivatives thereof
A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
A61K 45/00 - Medicinal preparations containing active ingredients not provided for in groups
A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
A61P 25/00 - Drugs for disorders of the nervous system
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
This method for analyzing a microobject includes: a step of setting a beam irradiation position on a photothermal conversion material; a step of concentrating a plurality of microobjects in the vicinity of the beam irradiation position by irradiating the photothermal conversion material with a beam; a step of changing the beam irradiation position to a concentrated region (stagnant region) in which the plurality of microobjects have been concentrated after concentration of the plurality of microobjects; a step of generating signal light (Raman scattering light (L3)) specific to the plurality of microobjects by irradiating the concentrated region with the beam; and a step of analyzing the plurality of microobjects on the basis of the detection result of the signal light by a photodetector (7).
NATIONAL UNIVERISTY CORPORATION HOKKAIDO UNIVERSITY (Japan)
DAICEL CORPORATION (Japan)
Inventor
Ishihara, Hajime
Wada, Takudo
Sasaki, Keiji
Makino, Yuto
Abstract
A particle discrimination mechanism includes: a channel in which a plurality of first nanoparticles each including an absorber having a predetermined absorption level and a plurality of second nanoparticles each of which does not include the absorber having the predetermined absorption level exist, the channel including a first input section and a second input section; a laser that outputs first light, which is absorbed by the absorber having the predetermined absorption level, in a direction from the first input section toward the second input section; a laser that outputs second light, which is not absorbed by the absorber having the predetermined absorption level but is scattered or absorbed by the second nanoparticles, in a direction from the second input section toward the first input section.
A method for quantitative determination of total polysulfide content (TPsC) and reactive polysulfide content (RPsC) includes a step of using liquid chromatography-electrospray ionization-tandem mass spectrometry.
The present addresses the problem of providing a new method for producing a metal and/or metalloid-containing sulfide. The problem is solved by a method for producing a metal and/or metalloid-containing sulfide characterized by using as a reaction medium and sulfur source a melt that can be obtained by heating a first sodium polysulfide represented by Na2Sx (in the formula, 1
C01B 17/20 - Methods for preparing sulfides or polysulfides, in general
H01M 4/58 - Selection of substances as active materials, active masses, active liquids of inorganic compounds other than oxides or hydroxides, e.g. sulfides, selenides, tellurides, halogenides or LiCoFySelection of substances as active materials, active masses, active liquids of polyanionic structures, e.g. phosphates, silicates or borates
The purpose of the present invention is to provide a novel biological material with excellent metal adsorption properties. A sulfated yeast containing a yeast and a sulfated polysaccharide on the surface of the yeast is useful as a novel biological material with excellent metal adsorption properties.
B01J 20/22 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof comprising organic material
B01J 20/28 - Solid sorbent compositions or filter aid compositionsSorbents for chromatographyProcesses for preparing, regenerating or reactivating thereof characterised by their form or physical properties
B01J 20/30 - Processes for preparing, regenerating or reactivating
C02F 1/28 - Treatment of water, waste water, or sewage by sorption
C22B 3/18 - Extraction of metal compounds from ores or concentrates by wet processes with the aid of microorganisms or enzymes, e.g. bacteria or algae
Provided is a cell activity measuring method that can, unlike conventional absorbance measurements or electrochemical measurements, evaluate the cell activity and the number of active cells by optically measuring scattered light from an insoluble reduced substance that becomes insoluble after being reduced in cells. This cell activity measuring method comprises: a deposition step for inputting measurement target cells in a measurement solution containing a soluble substance that has cell membrane permeability with respect to the measurement target cells and that can be reduced in active cells to form an insoluble reduced substance that is deposited in the active cells, and causing uptake of the soluble substance, formation of the insoluble reduced substance, and deposition of the same in the active cells; and, after the deposition step, an optical determination step for determining the cell activity level of respective cells on the basis of a specific color obtained by scattered light from the insoluble reduced substance in the cells in a deposited state.
This method for producing an isocyanate comprises: a step (1) for reacting a compound A having an element M-oxygen double bond with a compound B having an amino group to obtain a product C; and a step (2) for reacting the product C with at least one selected from the group consisting of carbon dioxide, a carbonate, and a hydrogen carbonate to obtain an isocyanate. The element M is a metal element or P. In the step (1), the ratio of the number of the element M-oxygen double bonds of the compound A to the number of moles of the amino group of the compound B is 0.5 or more.
The present invention addresses the problem of providing: a novel callus inducing agent; a method for inducing a callus using the callus inducing agent; a method for producing a callus; and a method for producing a plant body. Provided is a plant callus inducing agent comprising a compound represented by formula (I) (wherein R represents a halogen atom) or a salt thereof. Also provided are: a method for inducing a callus, the method including a step for bringing a plant body, a plant cell, a plant tissue piece or a plant seed into contact with the callus inducing agent to induce the formation of a callus; a method for producing a callus, the method further including a step for growing the induced callus; and a method for producing a plant body, the method including a step for inducing a callus and a step for inducing a shoot.
A01H 4/00 - Plant reproduction by tissue culture techniques
A01H 3/04 - Processes for modifying phenotypes by treatment with chemicals
A01H 6/20 - Brassicaceae, e.g. canola, broccoli or rucola
A01H 6/46 - Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
A01H 6/54 - Leguminosae or Fabaceae, e.g. soybean, alfalfa or peanut
A01N 47/34 - Ureas or thioureas containing the groups N—CO—N or N—CS—N containing the groups , e.g. biuretThio-analogues thereofUrea-aldehyde condensation products
Provided is a method for controlling a motion stabilized platform for Doppler Lidar with which it is possible to reduce the shaking of the Doppler Lidar itself and to achieve high-precision wind condition observations. A control method for reducing the motion of a motion stabilized platform that is installed on an offshore platform and has mounted thereto a Doppler Lidar for observing wind conditions, wherein the motion stabilized platform is installed on an offshore platform so as to be capable of movement, and the motion of the motion stabilized platform is controlled so that control torque is applied to the motion stabilized platform by using a variable damper.
F16F 15/02 - Suppression of vibrations of non-rotating, e.g. reciprocating, systemsSuppression of vibrations of rotating systems by use of members not moving with the rotating system
B63B 22/18 - Buoys having means to control attitude or position, e.g. reaction surfaces or tether
B63B 35/44 - Floating buildings, stores, drilling platforms, or workshops, e.g. carrying water-oil separating devices
F16M 11/12 - Means for attachment of apparatusMeans allowing adjustment of the apparatus relatively to the stand allowing pivoting in more than one direction
43.
RADIATION TREATMENT ASSISTANCE DEVICE, RADIATION TREATMENT ASSISTANCE PROGRAM, AND RADIATION TREATMENT SYSTEM
[Problem] To provide a radiation treatment assistance device, a radiation treatment assistance program, and a radiation treatment system capable of monitoring, in real time during radiation exposure, that a tumor moving due to respiration, heart movement, intestinal peristalsis, or the like remains in a planning target volume irradiated with a therapeutic radiation beam during MR-guided online-adaptive radiotherapy. [Solution] The present invention is provided with: a magnetic resonance image acquisition unit that acquires magnetic resonance image data of a region including the planning target volume of a therapeutic radiation beam; and an image synthesis unit that synthesizes preset contour image data for the magnetic resonance image data. The magnetic resonance image acquisition unit acquires first magnetic resonance image data that is a magnetic resonance image when the radiation is being radiated, and second magnetic resonance image data that is a magnetic resonance image when the radiation is not being radiated. The image synthesis unit synthesizes the second magnetic resonance image data and contour image data including image data of the contours of a gross tumor volume and image data of the contours of the planning target volume.
A61B 5/055 - Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fieldsMeasuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
44.
MICROSCOPIC OBJECT COLLECTING METHOD AND MICROSCOPIC OBJECT COLLECTING SYSTEM
A microscopic object collecting method collects a plurality of microscopic objects dispersed in a sample. The method includes: irradiating a thin film with a plurality of laser beams, the thin film being provided on a bottom surface of an collection container containing the sample, the plurality of laser beams being separated from each other; and heating the sample with the plurality of laser beams to generate a plurality of microbubbles corresponding to the plurality of laser beams and to generate heat convection in the sample. An interval between adjacent two laser beams of the plurality of laser beams is narrower than a distance that allows three larger microbubbles to be virtually arranged in a gap between two microbubbles corresponding to the two laser beams, each of the three larger microbubbles being the larger one of the two microbubbles.
This treatment tool is provided with: a main body (11); a hollow shaft (12) that is tubular and that is fixed to the main body (11); a snare wire (13) having two wire-shaped first portions and a second portion that is wire shaped and in which the two end parts are respectively continuous with one end part of each of the two first portions, the first portions being inserted into the hollow shaft (12); and a sliding member (15) to which the other end part of each of the two first portions with respect to the longitudinal direction is fixed, the sliding member (15) being supported by the main body (11) so as to be capable of sliding in the longitudinal direction of the hollow shaft (12) with respect to the main body (11). The second portion of the snare wire (13) is formed from an elastic material, and assumes an extended state of being extended so as to form a loop in a state of being exposed to the outside of the hollow shaft (12), and a contracted state of being folded into two at the center part in a state of being housed inside the hollow shaft (12).
The purpose of the present invention is to provide a new useful antibody against Hsp70. This anti-Hsp70 antibody recognizes a region, in Hsp70 protein, corresponding no. 461-490 in SEQ ID NO. 1, or has: as heavy chain complementation determination regions, HCDR1 having an amino acid sequence of no. 45-56, no. 50-56, or no. 45-54 in SEQ ID NO. 2, HCDR2 having an amino acid sequence of no. 71-86 or no. 72-78 in SEQ ID NO. 2, and HCDR3 having an amino acid sequence of no. 117-128 or no. 119-128 in SEQ ID NO. 2; and, as light chain complementation determination regions, LCDR1 having an amino acid sequence of no. 43-53 in SEQ ID NO. 15 or of no. 43-54, no. 47-52, no. 50-52, or no. 50-53 in SEQ ID NO. 3, LCDR2 having an amino acid sequence of no. 70-76, no. 70-71, or no. 70-75 in SEQ ID NO. 3, and LCDR3 having an amino acid sequence of no. 109-117 in SEQ ID NO. 3.
A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
A marker that can set a particularly clear cutoff value for distinguishing between follicular thyroid cancer (FTC) and follicular adenoma (FA), which is difficult in conventional pathological diagnosis is provided. Also provided are a method and a kit for diagnosing the development of FTC in a subject, comprising detecting expression of FAM19A2 in a sample derived from the thyroid tissue of the subject
C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
48.
DRUG FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES
The purpose of the present invention is to provide a medicine that exhibits the effect of inhibiting the aggregation of a causative protein of HRE-related neurodegenerative diseases such as ALS. Rifampicins selected from the group consisting of rifampicin, a derivative thereof, and salts thereof, and/or resveratrols selected from the group consisting of resveratrol and a derivative thereof act as an active ingredient of a drug for preventing or treating neurodegenerative diseases caused by the accumulation of TDP-43 or a drug for preventing or treating ALS.
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
A61P 25/00 - Drugs for disorders of the nervous system
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61P 43/00 - Drugs for specific purposes, not provided for in groups
49.
PREVENTIVE OR THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE
The purpose of the present invention is to provide a drug that exhibits the effect of inhibiting aggregation of a causative protein of an HRE-related neurodegenerative disease such as ALS. According to the present invention, rifampicin or a related substance selected from the group consisting of rifampicin, a derivative thereof, and salts thereof, and/or resveratrol or a related substance selected from the group consisting of resveratrol and a derivative thereof is an active ingredient of a preventive or therapeutic agent for a neurodegenerative disease caused by TDP-43 accumulation, or an active ingredient of a preventive or therapeutic agent for ALS.
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
A61P 25/00 - Drugs for disorders of the nervous system
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61P 43/00 - Drugs for specific purposes, not provided for in groups
50.
NOVEL FUMARIC ACID ESTER MONOMER, RESIN, AND FILM CONTAINING SAME
beta1 2 2 represents a linear alkyl group having 1 to 4 carbon atoms, a branched alkyl group having 3 to 12 carbon atoms, or a cyclic alkyl group having 3 to 6 carbon atoms.
G09F 9/00 - Indicating arrangements for variable information in which the information is built-up on a support by selection or combination of individual elements
To provide a metal recovery method that has a low environmental impact and that can achieve metal recovery at low cost and with high efficiency. A metal recovery method including: mixing a liquid containing a metal ion with a yeast to adsorb the metal ion by the yeast in the resulting mixed liquid; separating the yeast from the mixed liquid obtained in the adsorption process; and recovering the metal ion from the yeast separated in the separation process, wherein the metal ion to be adsorbed by the yeast in the adsorption process is a rare earth ion and/or a precious metal ion.
A method for identifying active sulfur, including: a step of labeling active sulfur in a sample with an alkylating agent; a step of adding a reducing agent to a portion of liquid extracted in the first step to decompose active sulfur; a step of applying the sample subjected to reduction treatment and the sample not subjected to reduction treatment after the labeling to an analyzer, comparing results of analysis of both samples, and determining components of signals disappeared by the reduction treatment as candidates for the active sulfur in the sample; a step of confirmation that the signals are derived from the alkylating agent; and a step of, after the confirmation, extraction and purification of the components of the signals from the sample, and performing structural analysis of the components.
G01N 24/08 - Investigating or analysing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
Provided is an agent for maintaining or improving cerebral function, the agent containing a crude drug selected from the leaf, fruit, or seed of Pipturus albidus.
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
54.
SOLID ELECTROLYTE MATERIAL, SOLID ELECTROLYTE COMPOSITE, ELECTRODE, AND METHOD FOR PRODUCING SOLID ELECTROLYTE MATERIAL
H01B 1/10 - Conductors or conductive bodies characterised by the conductive materialsSelection of materials as conductors mainly consisting of other non-metallic substances sulfides
H01B 1/06 - Conductors or conductive bodies characterised by the conductive materialsSelection of materials as conductors mainly consisting of other non-metallic substances
H01B 13/00 - Apparatus or processes specially adapted for manufacturing conductors or cables
The present invention inhibits an increase in the hardness of rice after storage by means of a rice cooking method that does not involve adding water and draining water. A method according to one embodiment of the present invention includes a superheated steam treatment step for treating raw rice contained in a container capable of holding a liquid with superheated steam in a chamber. The supply amount of superheated steam in the superheated steam treatment step is 20 kg/h∙m3to 150 kg/hm3 per unit time and unit volume of the chamber. In the superheated steam treatment step, water is not added and water is not drained in the container.
The present disclosure addresses the problem of providing a novel oxide-based positive electrode active material having exceptional charge/discharge characteristics. The aforementioned problem is solved by an oxide-based positive electrode active material that is a glass ceramic configured to include: Li or Na; at least one transition metal (groups 3 to 12 in periods 4 and 5); and ions selected from the group consisting of sulfate ions, silicate ions, aluminate ions, germanate ions, borate ions, nitrate ions, carbonate ions, and halide ions.
H01M 4/525 - Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of nickel, cobalt or iron of mixed oxides or hydroxides containing iron, cobalt or nickel for inserting or intercalating light metals, e.g. LiNiO2, LiCoO2 or LiCoOxFy
C03B 32/02 - Thermal crystallisation, e.g. for crystallising glass bodies into glass-ceramic articles
C03C 4/14 - Compositions for glass with special properties for electro-conductive glass
C03C 10/00 - Devitrified glass ceramics, i.e. glass ceramics having a crystalline phase dispersed in a glassy phase and constituting at least 50% by weight of the total composition
57.
METHOD FOR PRODUCING PHOTONIC DEVICE, AND PHOTONIC DEVICE
NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (Japan)
Inventor
Takahashi, Yasushi
Ota, Yushi
Ikuta, Shunsuke
Noda, Susumu
Asano, Takashi
Okano, Makoto
Abstract
The present invention reduces internal absorption of a photonic device. A method for producing a photonic device according to the present disclosure performs: a first step (step S30) in which a silicon (1) is processed by dry etching so as to obtain a specific shape (4); and a second step (step S50) in which a surface layer (4a) of the specific shape (4) is removed by chemical etching or thermal etching.
[Problem] To provide a treatment device and a treatment method that increase, and mitigate a decrease in, the efficiency of treatment for reducing the molecular weight of a liquid to be treated, by preventing air bubbles from blocking the flow of the liquid to be treated. [Solution] A treatment device 1 for treating a liquid to be treated by generating a plasma in a discharge gas is characterized by comprising a chamber 10, a pair of electrodes 112 for generating a plasma, and a dielectric 113 provided on the surface of the pair of electrodes 112, wherein: the chamber 10 includes a first container portion 12 in which the discharge gas is contained, a partition wall (isolating mechanism 11) constituting a wall surface of the first container portion 12, and a second container portion 13 in which the liquid to be treated is contained and which is connected to the first container portion 12 via a space (plasma generating portion 111) bored through the partition wall; the dielectric 113 is provided between the pair of electrodes 112 and the space; and a gas-liquid interface between the discharge gas and the liquid to be treated is formed in substantially the same plane as a main surface on the second container portion 13 side of the partition wall.
A semiconductor element and a method for manufacturing a semiconductor element improving heat dissipation are provided. A semiconductor element includes a Ga2O3(gallium oxide) substrate, a single-crystal SiC layer formed at one principal surface side of the Ga2O3 substrate, and a Schottky electrode formed at the one principal surface side of the Ga2O3 substrate and controls current flowing inside the Ga2O3 substrate.
H01L 29/16 - Semiconductor bodies characterised by the materials of which they are formed including, apart from doping materials or other impurities, only elements of Group IV of the Periodic System in uncombined form
H01L 29/04 - Semiconductor bodies characterised by their crystalline structure, e.g. polycrystalline, cubic or particular orientation of crystalline planes
H01L 29/26 - Semiconductor bodies characterised by the materials of which they are formed including, apart from doping materials or other impurities, elements provided for in two or more of the groups , , , ,
The purpose of the present invention is to provide a coordinate transformation procedure that allows for detailed analysis of motion such as walking by using motion information collected from one position. The present invention is a coordinate transformation method characterized by carrying out a procedure to: acquire three-dimensional skeletal information of a subject in motion who is described under a first coordinate system comprising a x' direction, a y' direction, and a z' direction, which are mutually orthogonal; use the skeletal information to calculate a Y direction being the traveling direction of the subject, a Z direction along the torso of the subject, and a X direction orthogonal to the Y direction and the Z direction; and transform the first coordinate system into a second coordinate system comprising the X direction, the Y direction, and the Z direction.
The purpose of the present invention is to generate a synthesized image from a magnetic resonance (MR) image of a patient, the synthesized image being similar to a PET image. One aspect of the present invention provides a medical image generation method characterized by causing execution of the steps of: acquiring a magnetic resonance (MR) image of a particular patient suspected of having a certain disease; and generating, from the MR image of the particular patient, a synthesized image similar to a PET image, using a trained model obtained by training an artificial intelligence model using, as training data, MR images of patients diagnosed to have the disease and positron emission tomography (PET) images corresponding to the MR images.
A61B 5/055 - Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fieldsMeasuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
A first step is preparing a sample in contact with a bowl region. A second step is irradiating the bowl region with a laser beam to generate a microbubble in an irradiation region of the laser beam and accumulate a plurality of microscopic objects around the microbubble. The bowl region includes a metallic thin film, a conductive polymer film, and a metallic thin film. Conductive polymer film has a plurality of bowl-like structures periodically arranged on metallic thin film. The sizes of the plurality of bowl-like structures and the irradiation region of the laser beam are determined such that at least two of the plurality of bowl-like structures are entirely included in the irradiation region.
G01N 33/569 - ImmunoassayBiospecific binding assayMaterials therefor for microorganisms, e.g. protozoa, bacteria, viruses
G01N 21/27 - ColourSpectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection
G01N 21/41 - RefractivityPhase-affecting properties, e.g. optical path length
Provided is a highly shape-stable wound retractor, which is for holding an opened part in a human body undergoing incision in an opened state, and which demonstrates shape stability during use. The highly shape-stable wound retractor is characterized: by containing, as a main resin component, a synthetic resin that has chemical resistance and is an elastic material; by being configured such that the wound retractor is curved elastically from a sheet-like state so that a first end and a second end overlap each other in the thickness direction to form a ring; and in that a through-hole through which the second end can pass is formed in the vicinity of the first end, and the diameter of the ring can be varied by changing the length over which the second end is passed through the through-hole.
A state classification method includes: acquiring measurement data of a physical quantity related to vibration measured for a vibrating device; outputting, by a deep learning model that includes an encoder and a decoder using a recurrent neural network and performs deep learning for predicting a future value of the measurement data for the device, an intermediate feature of the vibration from the encoder based on the measurement data; and classifying a state of the device using information based on the intermediate feature.
G06N 3/0442 - Recurrent networks, e.g. Hopfield networks characterised by memory or gating, e.g. long short-term memory [LSTM] or gated recurrent units [GRU]
65.
PREDICTIVE MODEL GENERATION DEVICE, PREDICTIVE MODEL GENERATION METHOD, ABNORMALITY DETECTION DEVICE, ABNORMALITY DETECTION METHOD, AND PROGRAM
Provided is a predictive model generation device capable of generating a predictive model that can be utilized for detecting abnormalities included in time series data. The predictive model generation device is provided with a training data acquisition unit that acquires training data, and a predictive model generation unit that generates a predictive model through machine learning using the training data. The predictive model is used in: an encoder unit that uses a first neural network to process time series data and generates an intermediate feature amount for each output node of the first neural network; and a decoder unit that uses a second neural network to process the intermediate feature amounts and predicts future values of the time series data. The predictive model generation unit generates a predictive model by carrying out machine learning in a direction that promotes orthogonalization of the intermediate feature amounts among the output nodes, and in a direction that causes the output of the second neural network to approximate the future values of the time series data input into the first neural network.
G06F 18/2411 - Classification techniques relating to the classification model, e.g. parametric or non-parametric approaches based on the proximity to a decision surface, e.g. support vector machines
G06N 3/0442 - Recurrent networks, e.g. Hopfield networks characterised by memory or gating, e.g. long short-term memory [LSTM] or gated recurrent units [GRU]
A detection kit includes a photothermal conversion region that absorbs light and converts the light into heat. A plurality of pores are disposed in the photothermal conversion region. A detection method includes first to third steps. The first step is introducing a plurality of antibody-modified beads into the plurality of pores, each of the plurality of antibody-modified beads having a surface modified by an antibody capable of being specifically bound to an analyte. The second step is heating a sample to generate convection in the sample by irradiating the photothermal conversion region with light having a wavelength within an absorption wavelength range of the photothermal conversion region. The third step is detecting the analyte by monitoring the detection kit after the irradiation with the light.
A transmitter includes a transmission unit configured to transmit a frame in which M symbols are arranged in a delay direction and in each of which N symbols are arranged in a Doppler direction and a transmit pulse application unit configured to apply a transmit pulse, in which N square-root Nyquist pulses or Nyquist pulses corresponding to a Nyquist interval T/M are arranged one for each time interval T, to the frame. Thereby, the transmitter can generate a signal substantially orthogonal with respect to a Doppler axis and a delay axis, even in a delay-Doppler domain.
This video display device comprises: a display that displays, on a display surface, a first image to be visually recognized by a first eye and a second image to be visually recognized by a second eye; an optical element that limits a first eye position in which the first image can be visually recognized and a second eye position in which the second image can be visually recognized; a position acquisition unit that acquires the first eye position and the second eye position; and a display control unit that determines a first image display pixel range and a second image display pixel range by using the first eye position and the second eye position each independently, and controls the display so that the first image is allocated to pixels included in the first image display pixel range and the second image is allocated to pixels included in the second image display pixel range. The display control unit determines a both-eye overlapping range that can be visually recognized by both the first eye and the second eye in the first image display pixel range and the second image display pixel range, and, upon determining that there is the both-eye overlapping range, controls the display so as to decrease luminance with respect to one or more pixels included in the both-eye overlapping range.
H04N 13/125 - Improving the 3D impression of stereoscopic images by modifying image signal contents, e.g. by filtering or adding monoscopic depth cues for crosstalk reduction
H04N 13/317 - Image reproducers for viewing without the aid of special glasses, i.e. using autostereoscopic displays using slanted parallax optics
H04N 13/366 - Image reproducers using viewer tracking
Provided is a rare earth element recovery method having low environmental impact and being capable of efficiently recovering a rare earth element at low cost. The rare earth element recovery method includes: an adsorption step for mixing a rare earth ion-containing liquid and torula yeast, and obtaining a mixed liquid in which rare earth ions are adsorbed on the torula yeast under acidic conditions; a separation step for separating the torula yeast from the mixed liquid obtained in the adsorption step; and a recovery step for recovering the rare earth ions from the torula yeast separated in the separation step.
The present invention provides a welding electrode capable of spot-welding a workpiece having a surface oxide film with stable welding quality, the welding electrode allowing general tip dressers to be used. The welding electrode of the present invention is used for spot welding of a workpiece. The welding electrode includes an end face provided so as to contact the workpiece, and at least one elongated groove provided in the end face or a plurality of blind holes provided in the end face. A depth of the groove or a depth of the blind holes is 0.5 mm or more and 20 mm or less. A ratio (d/w) of the depth d of the groove to a width w of the groove or a ratio (d/s) of the depth d of the blind holes to a size s of the blind holes is 2 or more.
NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (Japan)
Inventor
Tachibana, Taro
Ihara, Kanichiro
Hori, Yuichi
Shimizu, Kazuya
Abstract
The purpose of the present invention is to provide an antibody against pancreatic cancer stem cells. This antibody against pancreatic cancer stem cells includes a heavy chain variable region including heavy chain CDRs described as HCDR1-HCDR3, and a light chain variable region including light chain CDRs described as LCDR1-LCDR3, and has an ability to bind to pancreatic cancer stem cells, where HCDR1 has an amino acid sequence located at positions 26-35 in SEQ ID NO: 1 or a sequence analogous thereto, HCDR2 has a sequence located at positions 47-65 in SEQ ID NO: 1 or a sequence analogous thereto, HCDR3 has a sequence located at positions 96-104 in SEQ ID NO: 1 or a sequence analogous thereto, LCDR1 has a sequence located at positions 24-34 in SEQ ID NO: 2 or a sequence analogous thereto, LCDR2 has a sequence located at positions 46-56 in SEQ ID NO: 2 or a sequence analogous thereto, and LCDR3 has a sequence located at positions 89-96 in SEQ ID NO: 2 or a sequence analogous thereto.
C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Provided are a method of accurately reproducing, about a temperature-dependent physical constant of a solid substance, in a cyberspace, up to a high-temperature region, a change involved in a temperature rise and acquiring an estimated value conforming to an actual phenomenon, a program for causing a computes to execute the method, a recording medium storing the program, an apparatus including an arithmetic operation unit that executes the program, a processed product manufacturing method using the method, and a fatigue damage monitoring method. An estimated value acquisition method of the present invention is a method of acquiring an estimated value A of a temperature-dependent physical constant of a solid substance at a predetermined temperature, the method including data-assimilating a predicted value F of the physical constant calculated by a finite element method analysis to a measured value Y of the physical constant to acquire the estimated value A.
An object is to provide a novel oxide-based ion conductor with improved ion conductivity over lithium oxide. The problem is solved by a noncrystalline ion conductor represented by the following formula:(Li2-xO1-xAx)1-yZy (I) (where A is one or more atoms selected from F, Cl, Br, and I, x satisfies 0.1≤x≤0.7, Z is a network-forming oxide, a network-modifying oxide (excluding Li2O), or an intermediate oxide, and y satisfies 0≤y≤0.25, except for those in which A is I and Z is SiO2 when 0.2≤y≤0.25).
The present invention addresses the problem of providing a method for pretreating a specimen to accurately and conveniently quantify a disease biomarker protein in the specimen while preventing aggregation or adsorption of the biomarker protein to a container. Specifically, the present invention relates to a method for pretreating a specimen containing an aggregating biomarker protein, the method comprising mixing the specimen with sodium dodecyl sulfate (SDS). Moreover, the present invention relates to a method for quantifying an aggregating biomarker protein in a specimen, the method including a step of mixing the specimen with SDS, and a step of, after the aforesaid step, specifically detecting and quantifying the biomarker protein in the specimen.
H01B 13/00 - Apparatus or processes specially adapted for manufacturing conductors or cables
H01B 1/06 - Conductors or conductive bodies characterised by the conductive materialsSelection of materials as conductors mainly consisting of other non-metallic substances
H01B 1/10 - Conductors or conductive bodies characterised by the conductive materialsSelection of materials as conductors mainly consisting of other non-metallic substances sulfides
H01M 4/62 - Selection of inactive substances as ingredients for active masses, e.g. binders, fillers
A label corresponding to each of various bacteria and virus species is prepared, and a detector for detecting bacteria and/or virus in a sample to be tested is provided based on the attribute of the label. DPV detector includes an electrode chip, a voltage applying unit for applying a voltage in a predetermined range to the electrode chip, a current measuring unit for measuring a peak current value outputted from the electrode chip in accordance with the applied voltage, a data memory unit for storing in advance the peak current value and the applied voltage value at the time of the peak current for each of the plurality of types of metal nanostructures, a target specifying unit for comparing the measured data and the accumulated data of the current measuring unit to specify a target coupled to the metal nanostructure, and a displaying unit for displaying the specified target.
CALCULATION METHOD FOR HEATING PLAN, PROGRAM, RECORDING MEDIUM, DEVICE, DEFORMATION METHOD, PLATE DEFORMATION DEVICE, AND PRODUCTION METHOD FOR DEFORMED PLATE
To provide a calculation method that enables a heating plan for approximating a plate to an intended shape to be calculated in a short period of time.
To provide a calculation method that enables a heating plan for approximating a plate to an intended shape to be calculated in a short period of time.
A calculation method according to the present invention is a calculation method of a heating plan for deforming a plate by heating, the calculation method including: a Bayesian optimization step of performing a Bayesian optimization by inputting a training data group including a plurality of combinations of heating conditions that include a heating shape having been set at an arbitrary location of an analysis model for an original shape being a shape of the plate and a shape that has been calculated based on the heating conditions and determining a heating conditions candidate; and a finite element analysis step of converting the heating conditions candidate into strain data and performing a structural analysis based on a finite element method by inputting the strain data to output a shape candidate.
Provided is a solid catalyst which, even when coexisting with a catalyst poison, has excellent activity in decomposing plastics. The solid catalyst for plastic decomposition comprises a support and ruthenium fixed to the support, wherein the support is a composite metal oxide.
B01J 23/63 - Platinum group metals with rare earths or actinides
B01J 23/46 - Ruthenium, rhodium, osmium or iridium
C08J 11/16 - Recovery or working-up of waste materials of polymers by chemically breaking down the molecular chains of polymers or breaking of crosslinks, e.g. devulcanisation by treatment with inorganic material
C10G 1/10 - Production of liquid hydrocarbon mixtures from oil shale, oil-sand, or non-melting solid carbonaceous or similar materials, e.g. wood, coal from rubber or rubber waste
79.
SUBSTRATE FOR FORMING SEMICONDUCTOR DEVICE, SEMICONDUCTOR LAMINATED STRUCTURE, SEMICONDUCTOR DEVICE, METHOD FOR MANUFACTURING SUBSTRATE FOR FORMING SEMICONDUCTOR DEVICE, METHOD FOR MANUFACTURING SEMICONDUCTOR LAMINATED STRUCTURE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE
The present invention relates to a substrate (1) which is for forming a semiconductor device, and has: a diamond substrate (10); and a silicon carbide layer (20) disposed on a portion or the entirety of one surface (10a) of the diamond substrate (10), wherein the thickness of the silicon carbide layer (20) is at most 20 nm, and an arithmetic mean roughness Ra of a surface (20a) of the silicon carbide layer (20) is at most 0.5 nm.
H01L 21/02 - Manufacture or treatment of semiconductor devices or of parts thereof
B23K 20/00 - Non-electric welding by applying impact or other pressure, with or without the application of heat, e.g. cladding or plating
B32B 9/00 - Layered products essentially comprising a particular substance not covered by groups
H01L 21/20 - Deposition of semiconductor materials on a substrate, e.g. epitaxial growth
H01L 21/203 - Deposition of semiconductor materials on a substrate, e.g. epitaxial growth using physical deposition, e.g. vacuum deposition, sputtering
H01L 29/80 - Field-effect transistors with field effect produced by a PN or other rectifying junction gate
The present invention provides a stool collection system that can automatically collect and prepare the entirety of stool from a test subject on an ongoing basis. The stool collection system according to the present invention is characterized by comprising: a preparation chamber that is communicated with a toilet seat; a conveyance mechanism that disposes a container for collecting the stool at a prescribed position with respect to the toilet seat, and that recovers, into the interior of the preparation chamber, the container in which the stool was loaded; a drier for drying the recovered stool; a crusher that crushes the dried stool; and a packaging machine for packaging the crushed stool.
A three-dimensional display device includes a display panel that emits image light, a barrier panel overlapping the display panel in an optical path of the image light and including multiple shutter cells (S) switchable between a transmissive portion and a light-blocking portion, a position detector that detects a position of at least one of a first eye or a second eye of a viewer, and a controller that controls the display panel and the barrier panel. The controller calculates a cumulative error between a barrier pitch (Bp) and an image pitch (k) corresponding to positions of the first and second eyes of the viewer based on position detection information from the position detector, and controls, when a ratio of the calculated cumulative error to one dot is greater than a first ratio, the image pitch (k) to be greater by at least one dot to reduce the cumulative error.
The present invention provides an estimation method that can quickly and accurately estimate an estimation target included in an analysis condition. An estimation method according to the present invention is characterized by including: a measurement step for measuring measurement data at one or more measurement point; a first analysis step for using an analysis condition including an estimation target to perform an analysis and obtain an analysis result; a second analysis step for setting a value obtained by applying perturbation to the value of the estimation target used in the first analysis step as the value of the estimation target so as to perform an analysis and obtain an analysis result; and a calculation step for calculating a sensitivity matrix on the basis of the analysis result of the first analysis step and the analysis result of the second analysis step, calculating an error between the analysis result of the first analysis step and the measurement data at the measurement point or data calculated from the measurement data, and calculating the amount by which the value of the estimation target is to be changed from the sensitivity matrix and the error.
NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (Japan)
UNIVERSITY PUBLIC CORPORATION OSAKA (Japan)
Inventor
Nagata, Shinya
Suzuki, Akane
Shioyama, Takahiro
Sugimoto, Tadanori
Shinozaki, Yukino
Satsu, Masakazu
Ohtsuki, Chikara
Nakamura, Jin
Akiyoshi, Hideo
Nishida, Hidetaka
Mie, Keiichiro
Abstract
Provided is a porous body for capturing cancer cells, including a biocompatible inorganic material, the porous body for capturing cancer cells having biocompatibility and also having stability in a living body. The porous body for capturing cancer cells can be used for application related to cancer such as a treatment, a treatment assistance, a test, or a diagnosis.
Provided is a live bacteria quantifying method comprising: a deposition step in which bacteria is placed in a measuring vessel containing a redox substance that is permeable to the cell membranes of the live bacteria to be measured, that is oxidized or reduced within the cells, and that is deposited within the cells, and the bacteria and redox substance are mixed for a prescribed period of time; a current peak measurement step in which the measurement solution is electrochemically measured after the deposition step to determine the current peak of the residual redox substance; and a quantitative evaluation step in which the current peak difference is determined between the current peak of the residual redox substance measured in the current peak measurement step and the current peak of the initial redox substance measured in advance, and the live bacteria are quantitatively evaluated from the current peak difference.
This noble metal production method comprises: a base metal dissolution step for producing a noble-metal-containing raw material and a base metal eluate in which a base metal has been dissolved; a noble metal dissolution step for producing a noble metal eluate in which the noble metal contained in the noble-metal-containing raw material has been eluted; a heating step for heating the noble metal eluate in the range of 30-100°C; a noble metal adsorption step for adding a yeast to the noble metal eluate after heating and selectively adsorbing to the yeast noble metal ions included in the noble metal eluate; and a noble metal separation step for adding a reducer to a dispersion of the yeast to which the noble metal ions are adsorbed, and separating the noble metal which has become nanoparticles.
NATIONAL UNIVERSITY CORPORATION YAMAGATA UNIVERSITY (Japan)
UNIVERSITY PUBLIC CORPORATION OSAKA (Japan)
NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY (Japan)
Inventor
Makabe Koki
Nakanishi Takeshi
Asano Ryutaro
Abstract
Provided is a heterodimeric protein production method for heterodimeric proteins such as bispecific antibodies, by which it is possible to produce a heterodimeric protein composed solely of domains comprising natural amino acid sequences. This production method is a heterodimeric protein production method comprising a production step in which a dimeric protein including a reaction tag is reacted with a modifying protein for modifying the dimeric protein, to produce a heterodimeric protein. The dimeric protein including the reaction tag comprises a first monomeric protein and a second monomeric protein; the first monomeric protein comprises, in the following order, a first reaction tag and a first dimer formation domain capable of forming a dimer; the first reaction tag comprises a binding tag and a first C-intein; the second monomeric protein comprises, in the following order, a second reaction tag, the first dimer formation domain, and a second dimer formation domain capable of forming a dimer; the second reaction tag comprises a binding partner capable of binding to the binding tag, and a second C-intein; the modifying protein comprises a first modifying protein and a second modifying protein; the first modifying protein comprises a first N-intein capable of reacting with the first C-intein, and a first adduct added to the first monomeric protein; the second modifying protein comprises a second N-intein capable of reacting with the second C-intein, and a second adduct added to the second monomeric protein; the first adduct and the second adduct are different adducts; the first monomeric protein and the second monomeric protein form a dimer; and in the production step, the first N-intein of the first modifying protein reacts with the first C-intein of the first monomeric protein, the first adduct of the first modifying protein is joined to the first monomeric protein, the second N-intein of the second modifying protein reacts with the second C-intein of the second monomeric protein, and the second adduct of the second modifying protein is joined to the second monomeric protein.
C12N 15/62 - DNA sequences coding for fusion proteins
C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
This three-dimensional display device comprises: a display panel having a display surface including sub-pixels; a parallax barrier having a light-transmitting area and a light-blocking area; a position acquisition unit that acquires the positions of the user's eyes; and a controller that synthesizes a mixed image displayed on the display surface. The controller successively allocates a first image or a second image having a parallax with respect to the first image to n sub-pixels arranged in accordance with the parallax barrier. The parallax barrier has an aperture ratio of 0.5+m/2n, where m is an integer greater than or equal to 0 and less than n. The controller causes sub-pixels observed across one end of the light-transmitting area and sub-pixels observed across the other end of the light-transmitting area to display a low-luminance image. The number of sub-pixels displaying the low-luminance image is the same on the one end side and the other end side of the light-transmitting area.
G02B 30/30 - Optical systems or apparatus for producing three-dimensional [3D] effects, e.g. stereoscopic images by providing first and second parallax images to an observer’s left and right eyes of the autostereoscopic type involving parallax barriers
G09G 5/36 - Control arrangements or circuits for visual indicators common to cathode-ray tube indicators and other visual indicators characterised by the display of individual graphic patterns using a bit-mapped memory
G09G 5/37 - Details of the operation on graphic patterns
H04N 13/125 - Improving the 3D impression of stereoscopic images by modifying image signal contents, e.g. by filtering or adding monoscopic depth cues for crosstalk reduction
H04N 13/31 - Image reproducers for viewing without the aid of special glasses, i.e. using autostereoscopic displays using parallax barriers
H04N 13/317 - Image reproducers for viewing without the aid of special glasses, i.e. using autostereoscopic displays using slanted parallax optics
H04N 13/346 - Image reproducers using prisms or semi-transparent mirrors
H04N 13/366 - Image reproducers using viewer tracking
Provided is a kit for detecting a glycoprotein contained in a sample using an optical condensation system, the kit comprising microparticles respectively modified by host molecules and a dilution solution for diluting the sample, in which each of the host molecules binds specifically to the glycoprotein, the dilution solution comprises a blocking agent and a buffering agent, the pH value of the dilution solution is higher than the isoelectric point of the glycoprotein, the concentration of the blocking agent is lower than a concentration at which the non-specific adsorption between the host molecules is inhibited in an environment where a photo-induced force does not act on the host particles, and the salt concentration in the dilution solution is a concentration at which the microparticles modifying the host molecules cannot be precipitated by salting out.
Provided are a breath visualization system and method, a breath evaluation system and method, and a health evaluation system and method having simple configurations and capable of ensuring visualization of breath even when a front image of a face of a subject is captured by a camera. A breath visualization system comprising: an infrared camera that detects light in the infrared region emitted from a face of a subject to obtain image data; a processing unit that subtract, from first image data obtained at a first time (certain arbitrarily selected time), second image data obtained at second time (prior to the certain arbitrarily selected time) prior to the first time, to generate processed image data; and an output unit that outputs the processed image data.
This microbe accumulation method includes first to third steps for accumulating a plurality of types of microbes. The first step is a step for readying an accumulation substrate (13) provided with a plurality of pores (131). Each of the plurality of pores (131) has an opening capable of capturing, for each of the plurality of types of microbes, at least one microbe of each respective type, and a depth extending in a direction including a vertically downward component. The second step is a step for setting a laser light radiation condition. The third step is a step for radiating laser light, through a sample, onto the plurality of pores (131) in accordance with the radiation condition. The region irradiated with the laser light does not include a photothermal conversion material. The step for performing setting includes a step for setting the intensity of non-resonant light in a non-resonant-light irradiation range such that the magnitude of a vertically downward component of a light-induced force produced by irradiation of the non-resonant light is greater than the magnitude of a vertically upward component of a buoyancy force due to a liquid sample and also greater than the magnitude of a vertically upward component of a force produced by Brownian motion of molecules in the liquid sample.
The present invention addresses the problem of providing a novel bacteriolytic agent capable of lysing a bacterium belonging to the genus Enterococcus. Provided is a bacteriolytic agent against a bacterium belonging to the genus Enterococcus that comprises a lytic enzyme containing any of: (a) the amino acid sequence represented by SEQ ID NO. 1; (b) an amino acid sequence resulting from addition, deletion and/or substitution of one or more amino acids in the amino acid sequence represented by SEQ ID NO. 1; or (c) an amino acid sequence having a sequence identity of 90% or more with the amino acid sequence represented by SEQ ID NO. 1, or an active fragment thereof.
C12N 9/36 - Hydrolases (3.) acting on glycosyl compounds (3.2) acting on beta-1, 4 bonds between N-acetylmuramic acid and 2-acetylamino 2-deoxy-D-glucose, e.g. lysozyme
C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression
(2h-1)(2h)(2h)) pixels; and performs control to move, on the basis of positional data indicating hth eye positions, the position of at least one of a (2h-1)th interocular boundary, which is a boundary between the right eye and the left eye of the hth observer, and a (2h-1)th inter-observer boundary, which is a boundary between the hth observer and a (h+1)th observer.
G02B 30/32 - Optical systems or apparatus for producing three-dimensional [3D] effects, e.g. stereoscopic images by providing first and second parallax images to an observer’s left and right eyes of the autostereoscopic type involving parallax barriers characterised by the geometry of the parallax barriers, e.g. staggered barriers, slanted parallax arrays or parallax arrays of varying shape or size
G03B 35/24 - Stereoscopic photography by simultaneous viewing using apertured or refractive resolving means on screen or between screen and eye
H04N 13/31 - Image reproducers for viewing without the aid of special glasses, i.e. using autostereoscopic displays using parallax barriers
H04N 13/317 - Image reproducers for viewing without the aid of special glasses, i.e. using autostereoscopic displays using slanted parallax optics
H04N 13/368 - Image reproducers using viewer tracking for two or more viewers
93.
METHOD FOR PREDICTING DEFORMING OR RESIDUAL STRESS, AND PROGRAM
The present invention provides a prediction method (correction thermal shrinkage method) with which it is possible to accurately predict, in a short time, deforming or residual stress occurring due to a heated object returning to normal temperature. A prediction method according to the present invention includes predicting deforming or residual stress occurring due to a heated object returning to normal temperature, the prediction method being characterized by including: a condition-setting step for setting a first shrinkage region and a second shrinkage region in a model for analyzing the object, and setting a first temperature change amount in the first shrinkage region and a second temperature change amount in the second shrinkage region; and an analysis step for imparting a first shrinkage strain calculated from the first temperature change amount to the first shrinkage region, and imparting a second shrinkage strain calculated from the second temperature change amount to the second shrinkage region, to analyze elasticity or elastoplasticity.
G01N 3/00 - Investigating strength properties of solid materials by application of mechanical stress
B23K 31/00 - Processes relevant to this subclass, specially adapted for particular articles or purposes, but not covered by any single one of main groups
G01N 3/60 - Investigating resistance of materials, e.g. refractory materials, to rapid heat changes
G01N 25/18 - Investigating or analysing materials by the use of thermal means by investigating thermal conductivity
94.
PREDICTION METHOD AND PROGRAM FOR PREDICTING PLASTIC STRAIN DISTRIBUTION, RESIDUAL STRESS DISTRIBUTION, OR DEFORMATION
The present invention provides a prediction method that can predict a plastic strain distribution, deformation distribution, or residual stress distribution in a short time and with high accuracy. The prediction method according to the present invention is for predicting a plastic strain distribution, residual stress distribution, or deformation of an object, and includes a step for outputting predictive output data corresponding to a plastic strain distribution from predictive input data that includes heating conditions by using a machine learning model that has been trained using teaching data, which includes input data for learning that includes heating conditions and output data for learning that corresponds to a plastic strain distribution calculated from the heating conditions using a numerical analysis method.
G01N 3/00 - Investigating strength properties of solid materials by application of mechanical stress
B23K 31/00 - Processes relevant to this subclass, specially adapted for particular articles or purposes, but not covered by any single one of main groups
COMPOSITE FILM, SENSOR ELEMENT COMPRISING SAID COMPOSITE FILM, BODY FAT PERCENTAGE MEASURING DEVICE, AND ELECTROCHEMICAL CELL DEVICE, AND WEARABLE MEASURING DEVICE COMPRISING SAID SENSOR ELEMENT
The present invention provides a composite film that has electrical conductivity, mechanical strength and flexibility which resist being affected by moisture and are stable, and that can prevent position aberration and peeling in the case where the composite film is used in close contact with a body to be contacted; a sensor element, a body fat percentage measuring device, and an electrochemical cell device which are provided with the composite film; and a wearable measuring device including the sensor element. The composite film includes electroconductive nanoparticles and nanofibers, wherein the nanofibers have a plurality of gaps therebetween that are communicated with an outside; the electroconductive nanoparticles adhere to the surface of the nanofibers and exist in the plurality of gaps; the nanofibers are hydrophilic and biocompatible; and the composite film is electroconductive and is used in close contact with a body to be contacted that is hydrophilic-treated or that contains moisture.
A61B 5/0537 - Measuring body composition by impedance, e.g. tissue hydration or fat content
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
96.
NEGATIVE ELECTRODE COMPOSITE AND SECONDARY BATTERY
The present invention addresses the problem of providing a countermeasure against deposition of an alkali metal in cases where the alkali metal is used as a negative electrode. The above-described problem is solved by a negative electrode composite body that contains: a negative electrode active material which contains, as main components, Li and an element M that is solid soluble in Li; and a substance X which has a higher redox potential than the negative electrode active material, or a substance X which does not have electrode activity.
A micro-object concentration method comprises first to third steps. The first step is a step for preparing an optical fiber (50) having a tip provided with a metal thin film (52). The second step is a step for arranging the tip of the optical fiber (50) in a liquid in which a plurality of micro-objects are dispersed. The third step is a step in which light having a wavelength contained in the absorption wavelength region of the metal thin film (52) is introduced into the optical fiber (50), thereby heating the liquid around the tip of the optical fiber (50) and generating convection.
This detection method for a substance to be detected includes a step in which a sample is prepared that includes: a plurality of metal nanoparticles (11) (probe particles (1)), each of which is modified by a host molecule (12) that bonds specifically to the substance to be detected; and a plurality of microparticles (21) (probe particles (2)), each of which is modified by a host molecule (22) that bonds specifically to the substance to be detected. The preparation step includes combining the plurality of probe particles (1) and the plurality of probe particles (2), which mutually differ in size and material, so that: each of the plurality of probe particles (1) is of a size that allows diffusion by Brownian motion within the sample; each of the plurality of probe particles (2) is of a size that allows being subject to dissipative force caused by Mie scattering of nonresonant light; and each of the plurality of probe particles (1) includes a material that causes thermal convection to be produced within the sample by irradiation with nonresonant light.
G01N 33/542 - ImmunoassayBiospecific binding assayMaterials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
G01N 33/543 - ImmunoassayBiospecific binding assayMaterials therefor with an insoluble carrier for immobilising immunochemicals
The present invention provides: an anti-gpNMB antibody that binds to gpNMB and affects the same and that has an effect of such as removal of dysfunctional microglia; and a use application of the anti-gpNMB antibody. The anti-gpNMB antibody specifically binds to at least one site in a region from a PMEL-CAF-like domain to a PKD domain of gpNMB.
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
A61K 31/713 - Double-stranded nucleic acids or oligonucleotides
A61K 35/12 - Materials from mammalsCompositions comprising non-specified tissues or cellsCompositions comprising non-embryonic stem cellsGenetically modified cells
A61K 38/02 - Peptides of undefined number of amino acidsDerivatives thereof
A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
A61K 45/00 - Medicinal preparations containing active ingredients not provided for in groups
A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
A61P 25/00 - Drugs for disorders of the nervous system
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
The present invention provides a method for producing a light emitting element which is composed of a GaN semiconductor, the method comprising: a step in which a light emitting layer 12 that has a quantum well structure is formed on a substrate 10; a step in which a cap layer 13 that is formed of GaN is formed on the light emitting layer; and a step in which an oxide film 14 is formed on the cap layer. With respect to this method for producing a light emitting element, the oxide film is formed of an oxide of an element which can be diffused and infiltrated into Ga vacancies that are present within the cap layer that is configured from GaN.
H01L 33/32 - Materials of the light emitting region containing only elements of group III and group V of the periodic system containing nitrogen
H01L 33/06 - SEMICONDUCTOR DEVICES NOT COVERED BY CLASS - Details thereof characterised by the semiconductor bodies with a quantum effect structure or superlattice, e.g. tunnel junction within the light emitting region, e.g. quantum confinement structure or tunnel barrier
H01L 33/44 - SEMICONDUCTOR DEVICES NOT COVERED BY CLASS - Details thereof characterised by the coatings, e.g. passivation layer or anti-reflective coating
patents
